These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6181646)
1. Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies. Carrel S; de Tribolet N; Mach JP Acta Neuropathol; 1982; 57(2-3):158-64. PubMed ID: 6181646 [TBL] [Abstract][Full Text] [Related]
2. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Seeger RC; Rosenblatt HM; Imai K; Ferrone S Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367 [TBL] [Abstract][Full Text] [Related]
3. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398 [TBL] [Abstract][Full Text] [Related]
4. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells. Liao SK; Clarke BJ; Kwong PC; Brickenden A; Gallic BL; Dent PB Eur J Immunol; 1981 Jun; 11(6):450-4. PubMed ID: 7262181 [TBL] [Abstract][Full Text] [Related]
5. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors. de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147 [TBL] [Abstract][Full Text] [Related]
6. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD; Wikstrand CJ; Fredman P; MÃ¥nsson JE; Svennerholm L; Bigner DD Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468 [TBL] [Abstract][Full Text] [Related]
7. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG. Wikstrand CJ; Bigner SH; Bigner DD J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens. Saxton RE; Mann BD; Morton DL; Burk MW Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138 [TBL] [Abstract][Full Text] [Related]
10. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines. Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135 [TBL] [Abstract][Full Text] [Related]
11. Analysis of human tumor cells for Ia-like antigens with monoclonal antibodies. Howe AJ; Seeger RC; Molinaro GA; Ferrone S J Natl Cancer Inst; 1981 May; 66(5):827-9. PubMed ID: 6262557 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution. Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727 [TBL] [Abstract][Full Text] [Related]
13. Human glioma-associated antigens detected by monoclonal antibodies. Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861 [TBL] [Abstract][Full Text] [Related]
14. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma. Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615 [TBL] [Abstract][Full Text] [Related]
15. Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin. Wikstrand CJ; Bourdon MA; Pegram CN; Bigner DD J Neuroimmunol; 1982 Aug; 3(1):43-62. PubMed ID: 6284796 [TBL] [Abstract][Full Text] [Related]
16. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen. Bumol TF; Chee DO; Reisfeld RA Hybridoma; 1982; 1(3):283-92. PubMed ID: 6208129 [TBL] [Abstract][Full Text] [Related]
17. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930 [TBL] [Abstract][Full Text] [Related]
18. Five novel cell surface antigens of CNS neoplasms. Jennings MT; Jennings VD; Asadourian LL; Rosenblum M; Albino AP; Cairncross JG; Old LJ J Neurol Sci; 1989 Jan; 89(1):63-78. PubMed ID: 2926443 [TBL] [Abstract][Full Text] [Related]
19. Shared antigenic determinant expressed on various mammalian melanoma cells. Taniguchi M; Wakabayashi S Gan; 1984 May; 75(5):418-26. PubMed ID: 6204902 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones. Markers for gliomas and neuroblastomas. Bosslet K; Mennel HD; Rodden F; Bauer BL; Wagner F; Altmannsberger A; Sedlacek HH; Wiegandt H Cancer Immunol Immunother; 1989; 29(3):171-8. PubMed ID: 2471592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]